Century Therapeutics Inc (IPSC)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -525.363 | -54.206 | -35.22 | -28.343 | -32.263 |
Return on Equity (%) | 519.855 | 54.042 | -66.125 | -37.464 | -56.072 |
Return on Invested Capital (%) | -573.275 | -65.971 | -54.946 | -51.795 | -76.532 |
Operating Margin (%) | N/A | N/A | N/A | -2489.152 | -6006.801 |
Net Profit Margin (%) | N/A | N/A | N/A | -2518.407 | -6115.123 |
Book Value Per Share | 11.748 | 9.803 | 7.204 | 5.177 | 3.088 |
Earnings Per Share | -31.912 | -7.161 | -1.742 | -2.239 | -2.284 |
Cash Per Share | 5.889 | 3.637 | 1.026 | 1.441 | 0.791 |
Working Capital Per Share | 10.843 | 8.913 | 3.863 | 4.958 | 2.66 |
Operating Profit Per Share | N/A | N/A | N/A | 0.089 | 0.037 |
EBIT Per Share | -31.912 | -7.161 | -1.741 | -2.238 | -2.253 |
EBITDA Per Share | -31.912 | -7.161 | -1.741 | -2.238 | -2.253 |
Free Cash Flow Per Share | -31.718 | -6.035 | -0.993 | -1.86 | -2.273 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 7,48M | 7,48M | 55,01M | 58,47M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | 58,47M | N/A | 59,31M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -1723.953 | N/A | N/A | N/A | -3281.988 | N/A | N/A |
Net Profit Margin (%) | N/A | -1817.674 | N/A | N/A | N/A | -3282.105 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 90,13M |
Ratio cours/bénéfice | -0,66 |
Ratio prix/ventes | 40,3 |
Ratio prix/liquidités | 1,9 |
Ratio prix/valeur comptable | 0,49 |
Rendement de dividende | - |
Actions en circulation | 85,03M |
Volume moyen (1 semaine) | 429,19k |
Volume moyen (1 mois) | 635,72k |
Variation sur 52 semaines | -66,29% |
Plus haut sur 52 semaines | 5,51 |
Plus bas sur 52 semaines | 0,9501 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales